Crewe Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.1K Buy
479
+59
+14% +$4.72K ﹤0.01% 440
2025
Q4
$40K Buy
420
+51
+14% +$5K ﹤0.01% 393
2025
Q3
$36K Buy
369
+205
+125% +$21.2K ﹤0.01% 411
2025
Q2
$17.6K Sell
164
-39
-19% -$3.95K ﹤0.01% 389
2025
Q1
$20.5K Buy
203
+55
+37% +$5.54K ﹤0.01% 349
2024
Q4
$13.2K Buy
148
+36
+32% +$3.17K ﹤0.01% 403
2024
Q3
$9.39K Buy
112
+18
+19% +$1.42K ﹤0.01% 504
2024
Q2
$7.24K Sell
94
-148
-61% -$10.8K ﹤0.01% 738
2024
Q1
$16.6K Buy
+242
New +$15.6K ﹤0.01% 520
2023
Q4
Sell
-7
Closed -$370 452
2023
Q3
$370 Hold
7
﹤0.01% 407
2023
Q2
$379 Sell
7
-422
-98% -$22K ﹤0.01% 656
2023
Q1
$21.5K Sell
429
-134
-24% -$6.32K ﹤0.01% 418
2022
Q4
$26.1K Sell
563
-301
-35% -$13K ﹤0.01% 379
2022
Q3
$33K Buy
864
+141
+20% +$5.66K 0.01% 371
2022
Q2
$27K Buy
+723
New +$29.4K 0.01% 368
2020
Q4
Sell
-65
Closed -$2K 472
2020
Q3
$2K Buy
+65
New +$2.5K ﹤0.01% 479
2020
Q1
Sell
-73
Closed -$3K 187
2019
Q4
$3K Buy
+73
New +$3.06K ﹤0.01% 211

Other funds holding BSX